Menu Search
Equities

Multiplan Corp

MPLN:NYQ

Multiplan Corp

Actions
Health CareHealth Care Providers
  • Price (USD)0.2123
  • Today's Change-0.023 / -9.77%
  • Shares traded2.86k
  • 1 Year change-87.51%
  • Beta0.6962
Data delayed at least 15 minutes, as of Sep 20 2024 00:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Multiplan Corp had revenues fall -10.95% from 1.08bn to 961.52m, though the company grew net income from a loss of 572.91m to a smaller loss of 91.70m.
Gross margin74.55%
Net profit margin-122.73%
Operating margin-94.97%
Return on assets-18.20%
Return on equity-98.82%
Return on investment-18.68%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Multiplan Corp fell by 259.07m. However, the company earned 171.72m from its operations for a Cash Flow Margin of 17.86%. In addition the company used 249.79m on investing activities and also paid 180.99m in financing cash flows.
Cash flow per share-1.15
Price/Cash flow per share--
Book value per share0.9344
Tangible book value per share-7.15
More ▼

Balance sheet in USDView more

Multiplan Corp has a Debt to Total Capital ratio of 88.23%, a lower figure than the previous year's 260.31%.
Current ratio1.06
Quick ratio--
Total debt/total equity7.50
Total debt/total capital0.8823
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 84.15%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		-74.12
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.